Arbitral tribunal panel discards Adocia’s complaint against Eli Lilly
By Akshay Kedari  Date: 2019-08-24

Arbitral tribunal panel discards Adocia’s complaint against Eli Lilly

Following this move, Lilly would continue to focus on developing and discovering new treatments for people suffering from diabetes.

A Chicago-based arbitration panel has recently ruled in favor of U.S. pharma giant Eli Lilly and Co. in a claim filed by biotech firm Adocia S.A. over the companies' previous partnership on a rapid-acting insulin.

According to trusted sources, the panel comprising of three arbitrators lined a verdict claiming that Lilly acted appropriately regarding Adocia's intellectual property, but denied Lilly's smaller counterclaim ruling that the company is not liable for damages.

Commenting on the decision, Michael J. Harrington, Senior Vice President & General Counsel, Lilly, said that their firm is pleased with the panel's decision. He claims that their company conducts its business with integrity and is looking forward to putting this matter behind it and focusing on developing and discovering new treatments for people suffering from diabetes.

For the record, Adocia and Lilly inked a collaboration agreement in 2014. However, in 2017, Lilly terminated the agreement and halted its future manufacturing, commercialization and developments related to the program.

Apparently, Adocia filed claims against Lilly for misuse of its confidential information and advancements whereas Lilly filed counterclaims based on allegations that Adocia disguised those discoveries and confidential information which were issued in Adocia's claims.

Reports cite that the recent decision will not impact the 2018 verdict by the Tribunal to award Adocia USD 11.6 million in damages, including interest, as compensation over a disputed contractual milestone payment. Moreover, Adocia is expected to hold a conference call to answer shareholders’ questions in August 2019.

For the uninitiated, Lilly is one of the leading global health care firms that focus on clinical discoveries that make people’s life better across the world. The company employees work to develop life-changing medicines to patients, improves the management and understanding of disease, and helps communities through volunteerism and philanthropy.

Source Credit: https://www.businesswire.com/news/home/20190822005745/en/Adocia-Announces-American-Arbitration-Association-Tribunal-Dismissed

https://investor.lilly.com/news-releases/news-release-details/arbitration-panel-rules-favor-lilly-complaint-filed-adocia

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Amazon’s cloud business comes under U.S. antitrust scrutiny
Amazon’s cloud business comes under U.S. antitrust scrutiny
By Akshay Kedari

U.S. Federal Trade Commission (FTC) has recently expanded its investigation on Amazon beyond the retail operations to the company’s cloud computing business. Lately, the U.S. antitrust enforcers was seen interviewing software firms about Amazon...

Huawei to reportedly move its U.S. research center to Canada
Huawei to reportedly move its U.S. research center to Canada
By Akshay Kedari

  The U.S. plans to stop more foreign shipments to Huawei Huawei will be manufacturing some 5G equipment outside China The founder of Chinese communications giant Huawei Technologies has indicated that the company is planning to move its r...

Philips unveils its new AI workflow platform IntelliSpace at 2019 RSNA
Philips unveils its new AI workflow platform IntelliSpace at 2019 RSNA
By Akshay Kedari

Philips, a renowned Dutch electronics conglomerate, has reportedly launched IntelliSpace AI Workflow Suite, its new AI workflow platform at the 2019 RSNA. Through this new launch, the company has further expanded its AI portfolio. The workflow suite...

U.S. Justice Dept concludes its antitrust probe over eSIM technology
U.S. Justice Dept concludes its antitrust probe over eSIM technology
By Akshay Kedari

The U.S. telecom industry has lately seen a lot of ups and downs, since the advent of 5G technology and the highly criticized wireless carrier-switching technology. However, some advancements where made recently when the U.S. Department of Justice (D...

Pioneer Transformers acquires Power Partners from OpenGate Capital
Pioneer Transformers acquires Power Partners from OpenGate Capital
By Akshay Kedari

OpenGate Capital, a globally recognized private equity firm, reportedly announced that it has successfully sold Power Partners to a portfolio firm of New York based Mill Point Capital, Pioneer Transformers. OpenGate, on January 2016 acquired Power P...